NYSEMKT:DXR
Daxor Corp Stock News
$9.65
+0 (+0%)
At Close: Apr 26, 2024
Daxor Corporation Announces Pricing of $7.0 Million Registered Direct Offering
01:09pm, Monday, 20'th Jul 2020
NEW YORK, July 20, 2020 -- Daxor Corporation (NYSE American: DXR) (“Daxor” or the “Company”), an investment company with innovative medical instrumentation and biotechnology.
How Europe Kept Coronavirus Cases Low Even After Reopening
10:25am, Monday, 20'th Jul 2020
Even as a surge in cases forces a number of U.S. states to reimpose restrictions, Europe’s reopening is for the most part going according to plan. Experts put that down to changing patterns of behav
How Much Does Daxor's (NYSEMKT:DXR) CEO Make?
07:41pm, Thursday, 16'th Jul 2020
Michael Feldschuh has been the CEO of Daxor Corporation (NYSEMKT:DXR) since 2016, and this article will examine the...
Enrollment Commences Using the BVA-100® Diagnostic Blood Test NEW YORK, July 16, 2020 -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical.
Daxor Announces Initiation of First-of-Its-Kind Multicenter BVA-100® Study in Hospitalized Patients With COVID-19
12:00pm, Wednesday, 15'th Jul 2020
COVID-19 Investigation Commences at NYU Langone Health with Daxor’s Blood Volume Analysis Technology NEW YORK, July 15, 2020 -- Daxor Corporation (NYSE MKT: DXR), an.
Covid-19 : les Français attendent une relance verte
01:00pm, Monday, 13'th Jul 2020
Selon une étude BVA publiée par « Les Echos », les préoccupations de l'opinion n'ont pas été radicalement chamboulées par la crise sanitaire. Mais les valeurs de la famille, de la santé et
DAXOR ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH AMERICAN MEDICAL DEPOT GOVERNMENT DISTRIBUTOR
12:00pm, Wednesday, 08'th Jul 2020
Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, has signed a new distribution agreeme
Daxor Corporation Announces Appointment of Henry D. Cremisi, MD, FACP and Joy Goudie, Esq. to the Company’s Board of Directors
12:00pm, Tuesday, 30'th Jun 2020
Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced the appointments of D
Postalis passa bem pela crise, enquanto busca ressarcimento por perdas do passado
02:00pm, Sunday, 28'th Jun 2020
Fundo de pensão dos Correios consegue rentabilidade satisfatória em meio aos efeitos da pandemia, mas ainda carrega herança maldita de R$ 8,4 bilhões
Killer whale submarine to be auctioned in the Netherlands
03:46pm, Friday, 26'th Jun 2020
A submarine that is a replica of a killer whale, and which can perform aerial stunts like those seen in the film Free Willy, is set to be auctioned in The Netherlands. According to local media rep
Sub that looks like a killer whale and even LEAPS out of the water
10:38am, Thursday, 25'th Jun 2020
According to Dutch media, the two-person submarine reaches a top speed of 62 mph and can jump up to 16.4ft into the air. Underwater, the nifty vessel can hit speeds of 34 mph.
Brexit warning: How Macron's 'biggest rival' has chilling plan for UK
02:15pm, Wednesday, 24'th Jun 2020
EMMANUEL MACRON's biggest rival in the 2022 French Presidential election, Edouard Philippe, has a chilling plan for post-Brexit Britain, which could see the City of London sidelined as the continent's
Municipales: à Paris, Buzyn veut "jouer le match"
11:33am, Wednesday, 24'th Jun 2020
Une tournée médiatique tambour battant, une discrète campagne sur les pavés parisiens: Agnès Buzyn, candidate LREM arrivée troisième au premier tour des municipales à Paris, veut d'abord "joue
Vacances d'été 2020: pourquoi Auvergne-Rhône-Alpes a la cote
02:00pm, Tuesday, 23'rd Jun 2020
À l’heure des réservations pour cet été inédit, la région est l’une des destinations les plus prisées de l’Hexagone. Ses deux atouts ? Le Cantal et l'Ardèche.
Oxford scientists could double dose of Covid-19 vaccine in jab hope
12:00pm, Tuesday, 23'rd Jun 2020
In trials on pigs researchers found the vaccine being developed by scientists at Oxford appears to work better in a two-part 'prime' and 'boost' dosage - the same way the MMR jab is given.